Brief: Foghorn Therapeutics Q2 EPS USD -0.7
04/08/2023 12:00
Aug 04 (Reuters) - Foghorn Therapeutics Q2 net income USD -29.487 million. * Q2 collaboration revenue USD 5.599 million
FHTX — Foghorn Therapeutics News Story
0.000.00%
Last trade - 00:00- $118.77m
- -$48.81m
- $30.91m